Has Matthew Elias, DO received payments from drug or device companies?

Yes. Drug and device makers reported $210,428 in general payments to Matthew Elias, DO across 1,020 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Elias, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Elias, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Elias, DO

Dermatology · Fort Lauderdale, FLNPI 1114118163

Payments from drug & device makers

$210,428in general payments, 2019–2025

Across 1,020 payments — averaging $206.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$184K
Merz North America, Inc.$5K
Dermavant Sciences, Inc.$3K
Galderma Laboratories, L.p.$2K
Johnson & Johnson$2K
EPI Health, LLC$2K
plus $13K from 31 others

What the payments were for

Consulting fees$39,88219%
Speaking & faculty fees$129,70062%
Travel & lodging$19,5739%
Food & beverage$20,49410%
Education$7800%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	390	$184,038
Merz North America, Inc.	6	$5,448
Dermavant Sciences, Inc.	35	$3,067
Galderma Laboratories, L.p.	56	$1,621
Johnson & Johnson	102	$1,561
EPI Health, LLC	4	$1,524
Novartis	43	$1,337
Kerecis Limited	7	$1,331
Regeneron Healthcare Solutions, Inc.	53	$1,215
Sanofi	40	$1,207
UCB, Inc.	47	$1,040
Almirall LLC	6	$1,022
Incyte Corporation	46	$893
LEO Pharma Inc.	41	$668
Biofrontera Inc.	8	$582
Sun Pharmaceutical Industries Inc.	19	$571
Revance Therapeutics, Inc.	11	$463
Pfizer	8	$420
Sensus Healthcare, Inc.	2	$291
Arcutis Biotherapeutics, Inc.	20	$277
Ortho Dermatologics, A Division Of Bausch Health US, LLC	6	$236
Amgen	10	$234
Lilly USA, LLC	11	$211
E.r. Squibb & Sons, L.L.C.	8	$191
Verrica Pharmaceuticals Inc.	9	$176
Convatec Inc.	2	$157
Organon	7	$136
Triad Life Sciences Inc.	1	$119
VYNE Pharmaceuticals Inc.	6	$100
Strata Skin Sciences, Inc.	6	$75
Solta Medical, A Division Of Bausch Health US, LLC	3	$65
Bristol Myers Squibb	2	$42
Musculoskeletal Transplant Foundation Inc.	1	$28
Helsinn Therapeutics (U.S.), Inc.	1	$23
Organogenesis Inc.	1	$22
Paratek Pharmaceuticals, Inc.	1	$20
Merck	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$210,428 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024

$611,950

Medicare patients

660

Services billed

9,336

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Skyrizi PenRisankizumab-Rzaa	18	$380,519
Dupixent PenDupilumab	11	$39,062
Ketoconazole	242	$4,450
Triamcinolone Acetonide	214	$3,226
Clobetasol Propionate	52	$1,617
Fluocinonide	40	$1,194
Hydrocortisone	104	$711
Gentamicin Sulfate	18	$702
Fluorouracil	17	$594
Clindamycin Phosphate	21	$512
Mupirocin	77	$465
Metronidazole	12	$408
Imiquimod	14	$305
ValacyclovirValacyclovir Hcl	55	$284
Doxycycline Hyclate	68	$283

Paid to pharmacies, not to this prescriber.

Other dermatology in Fort Lauderdale

Jerome ObedFort Lauderdale$1.1M
Michael SherlingLake Worth$78.9M
Seth FormanTampa$28.2M
Thomas TaylorTampa$13.6M
Frank DonHallandale Beach$7.5M
Francisco FloresMiramar$6.7M
Hector Wiltz JrMiami$6.4M
Javier Alonso-LlamazaresCoral Gables$5.6M
Eduardo WeissHollywood$5.5M
Francisco KerdelMiami$5.1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →